跳至主要内容
临床试验/NCT02108197
NCT02108197已完成不适用

Obstructive Sleep Apnea and Gestational Diabetes : Incidence and Effects of Continuous Positive Airway Pressure Treatment on Glucose Metabolism

Ramathibodi Hospital2 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2014年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
82
试验地点
2
主要终点
glucose tolerance

研究概览

简要总结

The investigators hypothesize that pregnant women with gestational diabetes will have a high incidence of sleep apnea, and that the treatment of sleep apnea will lead to improved glucose control in these women.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • gestational diabetes

排除标准

  • pre-gestational diabetes

研究组 & 干预措施

CPAP Intervention

Experimental

Continuous positive airway pressure (S9, ResMed)

干预措施: Continuous positive airway pressure (S9, ResMed) (Device)

Wait-list

No Intervention

Wait list controls

结局指标

主要结局

glucose tolerance

时间窗: two weeks

Measuring glucose, fructosamine and insulin levels following a mixed meal test at 0 and 2 weeks. Glucose and insulin will be measured at 0 minutes and every 30 minutes thereafter for 2 hours. Fructosamine will be measured at 0 minutes only.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sirimon Reutrakul

Associate Professor of Medicine

Ramathibodi Hospital

研究点 (2)

Loading locations...

相似试验